VRPX — Virpax Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $0.03m
- -$1.49m
Annual cashflow statement for Virpax Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.34 | -12.1 | -21.7 | -15.2 | -12.1 |
| Non-Cash Items | 1.63 | 0.912 | 0.745 | 0.545 | 0.135 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.33 | -3.4 | 3.06 | 4.79 | -4.78 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.38 | -14.5 | -17.8 | -9.85 | -16.7 |
| Financing Cash Flow Items | -0.051 | -5.19 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.4 | 51.3 | 0 | — | 9.08 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.013 | 36.8 | -17.8 | -9.85 | -7.63 |